Two preliminary studies investigating disopyramide, a new anti-arrhythmic agent, demonstrated successful control of a variety of cardiac arrhythmias.
Get full access to this article
View all access options for this article.
References
1.
CheymolGGilbertJ C (1970) Recent Anti-arrhythmic Drugs. Vie Médicale39, 5361
2.
ColonnaD (1969) Disopyramide and Cardiac Rhythm Disorders. Gazette Médicale de France76, 6609
3.
DesruellesJ (1967) Our First Clinical Trials with Disopyramide (H 3292) in Cardiac Rhythm Disorders. Thérapie4, 937
4.
Editorial (1970) New anti-arrhythmic Agent Tested for Safety, Efficacy. Journal of American Medical Association213, 697
5.
GranierJ (1968) A New Anti-arrhythmic Drug—Disopyramide. Presse médicale32, 1605
6.
JequierR (1970) Pharmacology and Toxicology of Disopramide. Minerva medica.61, 3689
7.
KabelaE (1970) Experimental Study of Disopyramide as an Anti-arrhythmic Drug. Minerva medica.61, 3694
8.
KatzM J (1963) Clinical Evaluation of a New Anti-arrhythmic Agent, SC-7031. Current Therapeutic Research5, 343
9.
LomantoBLottoABossiM (1970) Clinical Use of Disopyramide in Arrhythmias due to Increased Excitability by Acute Myocardial Infarction. Minerva medica.61, 3769
10.
LyonA F (1972) Personal communication
11.
MokierC MVan ArmanC G (1962) Pharmacology of a New Anti-arrhythmic Agent, Diisopropyl-Amino-o-(2-Pyridyl)-Butyramide (SC 7031). Journal of Pharmacology and Experimental Therapeutics136, 114
12.
RanneyR E (1961) Disopyramide phosphate: Pharmacokinetic and Pharmacologic Relationships of a New Anti-arrhythmic Agent. Archives internationales de pharmacodynamie et de therapie191, 162
13.
SelviniA (1970) Disopyramide in the Prophylaxis of Arrhythmias in Myocardial Infarction. Minerva medica.61, 3774